• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

GLUCAGON-LIKE PEPTIDE 1

PPARgamma and drugs for Alzheimer’s and Diabetes

September 17, 2018Alzheimer's, Diabetes, Metabolic Disorders, Nervous System Disorders, Vizit Graphs
PPARgamma ad common drugs and two major diseases, Alzheimer’s and Diabetes

“Live graph” of PPARgamma associated with common drugs and two major diseases, Alzheimer’s and Diabetes. Explore the live graph.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

Vizit Graphs Tag Cloud

AUTOPHAGY CANCER ALZHEIMER'S DISEASE STREPTOCOCCUS PNEUMONIAE INSULIN RECEPTOR CD4 CELL DIFFERENTIATION ERBB-2 INFLAMMATION TH17 CELLS METFORMIN CASP3 ESCHERICHIA COLI PORPHYROMONAS GINGIVALIS AGING HELICOBACTER PYLORI IL17A NEURODEGENERATIVE DISORDERS CELL DEATH ANGIOGENESIS REMICADE IL6 BREAST CANCER IL23A LISTERIA MONOCYTOGENES CTLA4 PSEUDOMONAS AERUGINOSA CELL DIVISION IMMUNE RESPONSE TP53 APOPTOTIC PROCESS CANDIDA ALBICANS IFNG PARKINSON DISEASE CELL PROLIFERATION 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE STAPHYLOCOCCUS AUREUS SOD1 FOXP3 RHEUMATOID ARTHRITIS CLOSTRIDIUM DIFFICILE TNF DOXORUBICIN DIABETES MELLITUS

© 2020 Biovista Vizit All Rights Reserved.